Cargando…

Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice

Alzheimer’s disease (AD) is characterized by the progressive accumulation of amyloid-β and hyperphosphorylated tau (pTau), which can spread throughout the brain via extracellular vesicles (EVs). Membrane ceramide enrichment regulated by the enzyme neutral sphingomyelinase 2 (nSMase2) is a critical c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tallon, Carolyn, Bell, Benjamin J., Sharma, Anjali, Pal, Arindom, Malvankar, Medhinee M., Thomas, Ajit G., Yoo, Seung-Wan, Hollinger, Kristen R., Coleman, Kaleem, Wilkinson, Elizabeth L., Kannan, Sujatha, Haughey, Norman J., Kannan, Rangaramanujam M., Rais, Rana, Slusher, Barbara S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609094/ https://www.ncbi.nlm.nih.gov/pubmed/36297501 http://dx.doi.org/10.3390/pharmaceutics14102066

Ejemplares similares

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer’s disease
por: Tallon, Carolyn, et al.
Publicado: (2023)

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
por: Tallon, Carolyn, et al.
Publicado: (2023)

Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice
por: Huang, Meixiang, et al.
Publicado: (2023)

Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis
por: Hollinger, Kristen R., et al.
Publicado: (2022)

Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)

Inhibition of nSMase2 Reduces the Transfer of Oligomeric α-Synuclein Irrespective of Hypoxia
por: Sackmann, Valerie, et al.
Publicado: (2019)

Dendrimer-Conjugated Glutamate Carboxypeptidase II Inhibitor Restores Microglial Changes in a Rabbit Model of Cerebral Palsy
por: Sah, Nirnath, et al.
Publicado: (2023)

Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics
por: Sharma, Anjali, et al.
Publicado: (2018)

Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling
por: Yabu, T, et al.
Publicado: (2015)

Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation
por: Zhang, Fan, et al.
Publicado: (2016)

The Expression of PHOSPHO1, nSMase2 and TNAP is Coordinately Regulated by Continuous PTH Exposure in Mineralising Osteoblast Cultures
por: Houston, D. A., et al.
Publicado: (2016)

The nSMase2/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice
por: Matsuzaka, Yasunari, et al.
Publicado: (2020)

Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis
por: Kosaka, Nobuyoshi, et al.
Publicado: (2013)

nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe(−/−) Mice
por: Lallemand, Tom, et al.
Publicado: (2018)

Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
por: Zhu, Chunni, et al.
Publicado: (2021)

Scalable synthesis and validation of PAMAM dendrimer‐N‐acetyl cysteine conjugate for potential translation
por: Sharma, Rishi, et al.
Publicado: (2018)

Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration
por: Liaw, Kevin, et al.
Publicado: (2020)

Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi
por: Gu, LiZe, et al.
Publicado: (2013)

Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
por: Zhu, Chunni, et al.
Publicado: (2021)

Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma
por: Liaw, Kevin, et al.
Publicado: (2020)

Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model
por: Zhang, Zhi, et al.
Publicado: (2020)

Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders
por: Sharma, Anjali, et al.
Publicado: (2020)

Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture
por: Alnasser, Yossef, et al.
Publicado: (2018)

Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration
por: Wu, Tony, et al.
Publicado: (2023)

Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy
por: Nemeth, Christina L., et al.
Publicado: (2022)

Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via nSMase2/Smpd3, Satellite, and Immune Cells in Duchenne Muscular Dystrophy
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)

Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation
por: Álvarez-Fernández, Hadrián, et al.
Publicado: (2022)

Galactosylated hydroxyl‐polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning‐induced liver failure
por: Porterfield, Joshua E., et al.
Publicado: (2023)

Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome
por: Nance, Elizabeth, et al.
Publicado: (2017)

Correction to: Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome
por: Nance, Elizabeth, et al.
Publicado: (2018)

Systemic administration of dendrimer N‐acetyl cysteine improves outcomes and survival following cardiac arrest
por: Modi, Hiren R., et al.
Publicado: (2021)

Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro
por: Lang, Jennifer K., et al.
Publicado: (2016)

Dendrimer-Based N-Acetyl Cysteine Maternal Therapy Ameliorates Placental Inflammation via Maintenance of M1/M2 Macrophage Recruitment
por: Liu, Yang, et al.
Publicado: (2022)

Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase
por: Zhu, Jiang, et al.
Publicado: (2022)

Correction: Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase
por: Zhu, Jiang, et al.
Publicado: (2022)

Dendrimer Brain Uptake and Targeted Therapy for Brain Injury in a Large Animal Model of Hypothermic Circulatory Arrest
por: Mishra, Manoj K., et al.
Publicado: (2014)

Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury
por: Lei, Jun, et al.
Publicado: (2017)

Nanomedicine in cerebral palsy
por: Balakrishnan, Bindu, et al.
Publicado: (2013)

Dendrimers Target the Ischemic Lesion in Rodent and Primate Models of Nonarteritic Anterior Ischemic Optic Neuropathy
por: Guo, Yan, et al.
Publicado: (2016)

Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury
por: Cabeza, O. Arteaga, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_asgrpa9oq3cf2sm755129af0b4